The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nozinan 25 mg/ml solution for injection/infusion



Neuraxpharm Ireland LimitedPA23229/008/001

Main Information

Trade NameNozinan 25 mg/ml solution for injection/infusion
Active SubstancesLEVOMEPROMAZINE HYDROCHLORIDE
Dosage FormSolution for injection/infusion
Licence HolderNeuraxpharm Ireland Limited
Licence NumberPA23229/008/001

Group Information

ATC CodeN05AA Phenothiazines with aliphatic side-chain
N05AA02 levomepromazine

Status

License statusAuthorised
Licence Issued21/01/1983
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceConditions The following site is not to be used for manufacture or batch release: Aventis Pharma, Dagenham Rainham Road South Dagenham Essex RM10 7XS England Commitments A commitment has been made to delete the following site for manufacture and batch release by way of variation: Aventis Pharma, Dagenham Rainham Road South Dagenham Essex RM10 7XS England
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back